Sen. Bernie Sanders (I-Vt.), the ranking member on the Senate Committee on Health, Education, Labor, and Pensions, and Sen. Angus King (I-Maine) introduced new legislation on June 12 that would ban advertisements for prescription drugs on television and other platforms.
“This bill is a great step to ensure that patients are getting the best information possible and from the right source: their providers and not biased advertisements,” King added.
The pharmaceutical industry spent $5 billion on ads on national television alone in 2024, according to data cited by the senators. Companies have been able to advertise directly to consumers since 1997, when the U.S. Food and Drug Administration Modernization Act relaxed restrictions.
Pharmaceutical Research and Manufacturers of America, a trade industry group, did not respond to a request for comment on the new bill.
Sens. Chris Murphy (D-Conn.), Peter Welch (D-Vt.), Jeff Merkley (D-Ore.), and Dick Durbin (D-Ill.) signed on as co-sponsors for the Act.
Republicans control both chambers of Congress, so the senators would need to garner support among the GOP for the bill to pass. It’s not clear whether the White House supports the bill.
Kennedy said during a Senate Health Committee hearing in May that pharmaceutical advertising is typically done to “bury the existence and availability of generic drugs that are much cheaper and equally effective.” He added, “And the consumer is spending not his own money, but most often our money, taxpayer money.”
He also said that he supported a bill introduced by Sens. Josh Hawley (R-Mo.) and Jeanne Shaheen (D-N.H.) on the day of the hearing and would end tax deductions for pharmaceutical ads.







